Replies to post #212375 on Biotech Values

[DewDiligence]

Some Bavituximab diehards die really hard—e.g. #msg-132957013, #msg-132954939.

[DewDiligence]

PPHM update:

https://finance.yahoo.com/news/peregrine-pharmaceuticals-reports-financial-results-200500336.html

“As we focus on the CDMO business, we have been evaluating the best option for divesting our R&D assets through licensing or asset sale. The goal being to find a partner that will make a significant short term investment in the bavituximab program in order to validate the subset analysis from the Phase III SUNRISE trial.

Good luck with that, LOL.